Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
US-12173314-B2 · Dec 24, 2024 · US
US8936638B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8936638-B2 |
| Application number | US-201113825466-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 22, 2011 |
| Priority date | Sep 23, 2010 |
| Publication date | Jan 20, 2015 |
| Grant date | Jan 20, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention provides a method for producing bioactive coral bone graft substitutes and to products obtained thereby.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a bioactive coral bone graft substitute (BGS), the method comprising: growing coral in an artificial habitat containing a growth medium comprising at least one nutrient, the nutrient being absent from a coral natural habitat or being present in the coral natural habitat at a low concentration, and then harvesting the coral to obtain the bioactive coral BGS. 2. The method according to claim 1 , wherein the…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.